Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sivak

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Gastrointestinal Endoscopy|October 1, 1996
Clinical implications of endoscopic ultrasound: the American Endosonography Club StudyN J Nickl, M S Bhutani, M Catalano, et al.
Anesthesiology|June 12, 2018
Dexmedetomidine Prevents Excessive γ-Aminobutyric Acid Type A Receptor Function after AnesthesiaDian-Shi Wang, Kirusanthy Kaneshwaran, Gang Lei, et al.
Journal of Medicinal Chemistry|November 17, 2015
Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular DegenerationErik L Meredith, Nello Mainolfi, Stephen Poor, et al.
Journal of Medicinal Chemistry|February 6, 2018
The Discovery of N-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular DegenerationChristopher M Adams, Karen Anderson, Gerald Artman, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Gastrointestinal Endoscopy|October 1, 1996
Clinical implications of endoscopic ultrasound: the American Endosonography Club StudyN J Nickl, M S Bhutani, M Catalano, et al.
Anesthesiology|June 12, 2018
Dexmedetomidine Prevents Excessive γ-Aminobutyric Acid Type A Receptor Function after AnesthesiaDian-Shi Wang, Kirusanthy Kaneshwaran, Gang Lei, et al.
Journal of Medicinal Chemistry|November 17, 2015
Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular DegenerationErik L Meredith, Nello Mainolfi, Stephen Poor, et al.
Journal of Medicinal Chemistry|February 6, 2018
The Discovery of N-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular DegenerationChristopher M Adams, Karen Anderson, Gerald Artman, et al.
Pageof 9